Blood salvage produces higher total blood product costs in single-level lumbar spine surgery

Spine

Volumn 38, Issue 8, 2013, Pages 703-708

  Canan, Chelsea E ^a,b   Myers, John A ^b   Owens, Roger Kirk ^a   Crawford, Charles H ^a   Djurasovic, Mladen ^a   Burke, Lauren O ^a   Bratcher, Kelly R ^a   McCarthy, Kathryn J ^a   Carreon, Leah Y ^a  

^a NORTON LEATHERMAN SPINE CENTER   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

blood management; blood salvage; blood transfusion; cell saver; incremental cost effectiveness; lumbar fusion

Indexed keywords

ADULT; AGED; ALLOGENEIC BLOOD TRANSFUSION; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD SALVAGE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; BLOOD VOLUME; CELL SAVER RECOVERY SYSTEM; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HUMAN; INTRAOPERATIVE PERIOD; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POSTERIOR LUMBAR DECOMPRESSION AND FUSION; POSTERIOR SPINE FUSION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RETROSPECTIVE STUDY; REVIEW; SPINAL CORD DECOMPRESSION; SPINE SURGERY; SURGICAL EQUIPMENT; TRANSFUSION RELATED ACUTE LUNG INJURY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; COST-BENEFIT ANALYSIS; DECOMPRESSION, SURGICAL; FEMALE; HUMANS; INTRAOPERATIVE CARE; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE CARE; QUALITY-ADJUSTED LIFE YEARS; RETROSPECTIVE STUDIES; SPINAL FUSION; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84876387909     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3182767c8c     Document Type: Review

References (24)

1. Sharma S, Sharma P, Tyler LN. Transfusion of blood and blood products: Indications and complications. Am Fam Physician 2011; 83: 719-24
2. Bailey TE, Mahoney OM. The use of banked autologous blood in patients undergoing surgery for spinal deformity. J Bone Joint Surg Am 1987; 69: 329-32
3. Bowen RE, Gardner S, Scaduto AA, et al. Effi cacy of intraoperative cell salvage systems in pediatric idiopathic scoliosis patients undergoing posterior spinal fusion with segmental spinal instrumentation. Spine 2010; 35: 246-51
4. Moran MM, Kroon D, Tredwell SJ, et al. The role of autologous blood transfusion in adolescents undergoing spinal surgery. Spine 1995; 20: 532-6
5. Novak RW. Autologous Blood transfusion in a pediatric population: Safety and effi cacy. Clin Pediatr 1988; 27: 184-7
6. Cha CW, Deible C, Muzzonigro T, et al. Allogeneic transfusion requirements after autologous donations in posterior lumbar surgeries. Spine 2002; 27: 99-104
7. Gause PR, Siska PA, Westrick ER, et al. Effi cacy of intraoperative cell saver in decreasing postoperative blood transfusions in instrumented posterior lumbar fusion patients. Spine 2008; 33: 571-5
8. Johnson RG, Murphy M, Miller M. Fusions and tranfusions: An analysis of blood loss and autologous replacement during lumbar fusions. Spine 1989; 14: 358-62
9. Nuttall GA, Horlocker TT, Santrach PJ, et al. Predictors of blood transfusions in spinal instrumentation and fusion surgery. Spine 2000; 14: 596-601
10. Higgins AM, Harris AH. Health economic methods: Cost-minimization, cost-Effectiveness, cost-utility, and cost-benefi t evaluations. Crit Care Clin 2012; 28: 11-24
11. Russell LB, Gold MR, Siegel JE, et al. The role of cost-Effectiveness analysis in health and medicine. Panel on cost-Effectiveness in health and medicine. JAMA 1996; 276: 1172-7
12. Weinstein MC, Skinner JA. Comparative effectiveness and health care spending-implications for reform [published online ahead of print January 6, 2010]. N Engl J Med 2010; 362: 460-5
13. Gold MR, Siegel JE, Russel LB, et al. Cost-Effectiveness in Health and Medicine. New, NY: Oxford University Press; 1996
14. Laupacis A, Feeny D, Detsky AS, et al. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 1992; 146: 473-81
15. Winkelymayer WC, Weinstein MC, Mittelman MA, et al. Health economic evaluations: The special case of end-stage renal disease treatment. Med Decis Making 2002; 22: 417-30
16. Bambha K, Kim WR. Cost-Effectiveness analysis and incremental cost-Effectiveness ratios: Uses and pitfalls. Eur J Gastroenterol Hepatol 2004; 16: 519-26
17. McCabe C, Claxton K, Culyer AJ. The NICE cost-Effectiveness threshold: What it is and what that means. Pharmacoeconomics 2008; 26: 733-44
18. Loomes G, McKenzie L. The use of QALYs in health care decision making. Soc Sci Med 1989; 28: 299-308
19. Daubs MD, Lenke LG, Cheh G, et al. Adult spinal deformity surgery: Complications and outcomes in patients over age 60. Spine (Phila Pa 1976) 2007 ; 32: 2238-44
20. Glassman SD, Hamill CL, Bridwell KH, et al. The impact of perioperative complications on clinical outcome in adult deformity surgery. Spine (Phila Pa 1976) 2007 ; 32: 2764-70
21. Dawson E, Bae HW, Burkus JK, et al. Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. J Bone Joint Surg Am 2009; 91: 1604-13
22. Delamarter R, Zigler JE, Balderston RA, et al. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement compared with circumferential arthrodesis for the treatment of two-level lumbar degenerative disc disease: Results at twenty-four months. J Bone Joint Surg Am 2011; 93: 705-15
23. Dimar JR II, Glassman SD, Burkus JK, et al. Two-year fusion and clinical outcomes in 224 patients treated with a single-level instrumented posterolateral fusion with iliac crest bone graft. Spine J 2009; 9: 880-85
24. Ohtori S, Suzuki M, Koshi T, et al. Single-level instrumented posterolateral fusion of the lumbar spine with a local bone graft versus an iliac crest bone graft: A prospective, randomized study with a 2-year follow-up. Eur Spine J 2011; 20: 635-639